These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 10992905)

  • 1. [Leukocyte depletion of blood products: a requirement for improvement of quality and safety].
    De Pauw BE; Van den Bos A
    Ned Tijdschr Geneeskd; 2000 Sep; 144(36):1754-6. PubMed ID: 10992905
    [No Abstract]   [Full Text] [Related]  

  • 2. [Leukodepletion of blood products: a requirement for improvement of quality and safety].
    van Aken WG; Brand A; van der Poel CL
    Ned Tijdschr Geneeskd; 2000 May; 144(22):1033-6. PubMed ID: 10850104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukoreduction of the blood supply in Rhode Island.
    Sweeney JD
    Med Health R I; 1998 Dec; 81(12):386-91. PubMed ID: 9884537
    [No Abstract]   [Full Text] [Related]  

  • 4. Balancing evidence and public opinion in health technology assessments: the case of leukoreduction.
    Cleemput I; Leys M; Ramaekers D; Bonneux L
    Int J Technol Assess Health Care; 2006; 22(4):403-7. PubMed ID: 16984672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worth the cost?
    Ortolon K
    Tex Med; 2004 Jan; 100(1):43-5. PubMed ID: 15146771
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the leuko-reductive efficacy of single-donor erythropheresis procedures].
    Domingo JM; Rabasa P; Chueca P; Medarde A
    Sangre (Barc); 1999 Jun; 44(3):238-40. PubMed ID: 10481589
    [No Abstract]   [Full Text] [Related]  

  • 7. Material & equipment, procurement & maintenance: Impact on blood safety.
    Emmanuel JC
    Biologicals; 2010 Jan; 38(1):78-80. PubMed ID: 20079663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitals deal with blood shortages, filtration cost.
    DeJohn P
    Hosp Mater Manage; 2001 Apr; 26(4):1, 9. PubMed ID: 11329976
    [No Abstract]   [Full Text] [Related]  

  • 9. Prestorage leukocyte reduction of cellular blood components.
    Dzik S
    Transfus Sci; 1994 Jun; 15(2):131-9. PubMed ID: 10147358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA could OK costly blood standards. An expert says that like chicken soup, removal of white cells from blood supply can't hurt.
    Hensley S
    Mod Healthc; 1999 Nov; 29(48):8. PubMed ID: 10662211
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma for fractionation: safety and quality issues.
    Farrugia A
    Haemophilia; 2004 Jul; 10(4):334-40. PubMed ID: 15230946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing blood component preparation: qualitative, logistic and economic aspects.
    Högman CF; Eriksson L
    Biomed Biochim Acta; 1990; 49(2-3):S198-203. PubMed ID: 2117446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evolution of the practices of labile blood product distribution].
    Tardivel R
    Transfus Clin Biol; 2005 Jun; 12(2):177-9. PubMed ID: 15894509
    [No Abstract]   [Full Text] [Related]  

  • 14. The implementation of rapid cooling and overnight hold of whole blood at ambient temperature before processing into components in Israel.
    Shinar E; Etlin S; Frenkel O; Yahalom V
    Transfusion; 2011 Jan; 51 Suppl 1():58S-64S. PubMed ID: 21223297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood program in Japan: current status.
    Ikeda H
    Transfus Apher Sci; 2002 Apr; 26(2):129-33. PubMed ID: 12121069
    [No Abstract]   [Full Text] [Related]  

  • 16. Bedside processing.
    Krause KP
    Vox Sang; 2004 Jul; 87 Suppl 2():76-8. PubMed ID: 15209884
    [No Abstract]   [Full Text] [Related]  

  • 17. The Norwegian Plasma Fractionation Project--a 12 year clinical and economic success story.
    Flesland O; Seghatchian J; Solheim BG
    Transfus Apher Sci; 2003 Feb; 28(1):93-100. PubMed ID: 12620274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Developments in blood transfusion].
    Krusius T; Porkka K
    Duodecim; 2004; 120(7):857-9. PubMed ID: 15154306
    [No Abstract]   [Full Text] [Related]  

  • 19. Options and cost effectiveness of multicomponent blood collection.
    Matthes GA
    Transfus Apher Sci; 2002 Oct; 27(2):115-21. PubMed ID: 12350046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Various methods for good blood supply in Scandinavia].
    Oldinger E
    Nord Med; 1996 Sep; 111(7):212-8. PubMed ID: 8927533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.